Kelley Bishop, MD
Family Medicine · Jackson, MSNPI 1679596613
Payments from drug & device makers
Across 51 payments — averaging $48.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$2K
- Lilly USA, LLC$278
- Novo Nordisk$140
- Pfizer$102
- AbbVie$55
- Phathom Pharmaceuticals, Inc.$45
- plus $271 from 10 others
What the payments were for
- Consulting fees$1,60064%
- Food & beverage$89036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 1 | $1,600 |
| Lilly USA, LLC | 16 | $278 |
| Novo Nordisk | 7 | $140 |
| Pfizer | 6 | $102 |
| AbbVie | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $40 |
| Shield Therapeutics Inc | 2 | $38 |
| Amgen | 2 | $36 |
| GSK | 2 | $31 |
| AstraZeneca | 2 | $30 |
| Global Blood Therapeutics, Inc. | 2 | $27 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $18 |
| Merck | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
How this compares
$2,490 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 71 | $90,833 |
| OzempicSemaglutide | 39 | $53,315 |
| MounjaroTirzepatide | 25 | $32,543 |
| EliquisApixaban | 18 | $25,919 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $20,519 |
| JanuviaSitagliptin Phosphate | 20 | $20,519 |
| FarxigaDapagliflozin Propanediol | 14 | $20,416 |
| LinzessLinaclotide | 22 | $16,227 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,574 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $7,992 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,716 |
| Colchicine | 22 | $6,419 |
| Humulin 70-30Insulin Nph Hum/Reg Insulin Hm | 17 | $2,915 |
| Gabapentin | 140 | $2,577 |
| Atorvastatin Calcium | 228 | $1,786 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $140 | $54,30653 claims |
| Lilly USA, LLCMounjaro, Humulin 70-30 | $278 | $35,45842 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $30 | $28,99027 claims |
| PfizerEliquis | $102 | $25,91918 claims |
| MerckJanuvia | $15 | $20,51920 claims |
| AbbVieLinzess, Synthroid | $55 | $17,71342 claims |
| GSKTrelegy Ellipta | $31 | $7,71611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Jackson
- Alexander OsowaJackson$2.2M
- Andrea PhillipsJackson$268K
- Dava ClevelandJackson$100K
- Massie HeadleyJackson$10K
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.